BMY monthly performance report
View BMY's monthly returns, drawdown, and seasonality trends — updated every month.
BMY monthly report
—
Key takeaways
- Bristol Myers Squibb (BMY) closed November 2026 at $62.32, down 0.26% for the month and +26.98% over the trailing 12 months.
- Year-to-date, BMY is +15.54%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +3.39% versus its 200-day moving average ($60.28), a bullish technical signal.
- Over the past three years, BMY has underperformed the S&P 500 by −48.70%, with a relative strength index reading of 72.2.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Bristol Myers Squibb ended November 2026 at $62.32, posting a monthly return of −0.26%. The S&P 500 returned +0.19% over the same window, leaving relative performance at −0.44%.
The current quarter stands at −0.13% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +3.39% versus the 200-day moving average ($60.28).
Year-to-date, BMY is +15.54% against SPY +11.03%, a gap of +4.51%. The stock is currently −9.21% below its 52-week high, with maximum 3-year drawdown at −32.50%.
| Period | BMY | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.94% | −0.35% | −0.58% |
| 1 Week | −1.28% | +3.29% | −4.57% |
| 1 Month | −0.26% | +0.19% | −0.44% |
| 3 Months | −2.37% | −2.48% | +0.11% |
| 6 Months | +10.52% | +2.00% | +8.52% |
| YTD | +15.54% | +11.03% | +4.51% |
| 12 Months | +26.98% | +10.79% | +16.19% |
| 3 Years | +23.14% | +71.83% | −48.70% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2024 | +14.52% |
| #2 | Jul 2026 | +13.35% |
| #3 | Feb 2026 | +13.30% |
| #4 | Dec 2025 | +9.63% |
| #5 | Aug 2025 | +8.94% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2024 | −18.97% |
| #2 | Apr 2025 | −17.69% |
| #3 | Oct 2023 | −11.22% |
| #4 | Sep 2026 | −6.60% |
| #5 | May 2024 | −6.49% |
| Quarter | Return |
|---|---|
| Q3 2025 | −2.57% |
| Q4 2025 | +19.60% |
| Q1 2026 | +12.44% |
| Q2 2026 | −5.00% |
| Q3 2026 | +8.30% |
| Q4 2026 (QTD) | −0.13% |
| Year | Return |
|---|---|
| 2023 | −28.69% |
| 2024 | +10.23% |
| 2025 | −4.63% |
| 2026 | +15.54% |
| Metric | Value |
|---|---|
| 52-Week High | $68.64 (2026-08-19) |
| 52-Week Low | $45.27 (2025-11-20) |
| Current Price | $62.32 |
| 200-Day Moving Average | $60.28 |
| Price vs 200DMA | +3.39% |
| 3-Year Maximum Drawdown | −32.50% (2025-10-29) |
| Current Drawdown from 52W High | −9.21% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 72.2 |
| 3-Year Excess Return vs S&P 500 | −48.70% |
| RS Peak | 100.7 (Nov 2023) |
| RS Trough | 54.4 (Oct 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was BMY's return for this report period?
BMY returned −0.26% in the latest monthly window ending 2026-11-12.
Has BMY outperformed SPY year to date?
YTD BMY: +15.54% vs SPY: +11.03%.
What is BMY's 12-month return?
+26.98% over the trailing 12 months.
Is BMY above or below its 200-day moving average?
Price is +3.39% versus 200DMA ($60.28).
What is the maximum drawdown in the 3-year window?
−32.50% on 2025-10-29.